Kardium collects funding in Fidelity-led round

Vancouver, Canada-based Kardium Inc, a developer of a globe mapping and ablation system for the treatment of atrial fibrillation, has raised US$115 million in funding.

Vancouver, Canada-based Kardium Inc, a developer of a globe mapping and ablation system for the treatment of atrial fibrillation, has raised US$115 million in funding. Fidelity Management & Research Company LLC. led the round with participation from funds and accounts advised by T. Rowe Price Associates Inc.

Source: Press Release